These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29955517)

  • 21. Assessment of Gender-Affirming Hormone Therapy Requirements.
    Fernandez JD; Kendjorsky K; Narla A; Villasante-Tezanos AG; Tannock LR
    LGBT Health; 2019 Apr; 6(3):101-106. PubMed ID: 30810452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Take the T out, put the T in: Gender-affirming hormones in youth.
    Ehrensaft D; Tishelman AC
    Andrology; 2021 Nov; 9(6):1698-1706. PubMed ID: 34048640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
    Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
    J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Social Determinants of Discrimination and Access to Health Care Among Transgender Women in Oregon.
    Garcia J; Crosby RA
    Transgend Health; 2020; 5(4):225-233. PubMed ID: 33376802
    [No Abstract]   [Full Text] [Related]  

  • 26. When Gender Identity Doesn't Equal Sex Recorded at Birth: The Role of the Laboratory in Providing Effective Healthcare to the Transgender Community.
    Goldstein Z; Corneil TA; Greene DN
    Clin Chem; 2017 Aug; 63(8):1342-1352. PubMed ID: 28679645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of gender-affirming hormone therapy on cardiovascular and skeletal health: A literature review.
    Chan Swe N; Ahmed S; Eid M; Poretsky L; Gianos E; Cusano NE
    Metabol Open; 2022 Mar; 13():100173. PubMed ID: 35282421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy Care in Transgender Patients.
    Waldman G; Benson R
    Curr Neurol Neurosci Rep; 2022 Aug; 22(8):451-458. PubMed ID: 35666366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-Affirming Hormone Therapy for Transgender Men.
    Moravek MB
    Clin Obstet Gynecol; 2018 Dec; 61(4):687-704. PubMed ID: 30285972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment.
    Masumori N; Nakatsuka M
    Circ Rep; 2023 Apr; 5(4):105-113. PubMed ID: 37025940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Position statement on the hormonal management of adult transgender and gender diverse individuals.
    Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
    Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-affirming endocrine care for youth with a nonbinary gender identity.
    Hodax JK; DiVall S
    Ther Adv Endocrinol Metab; 2023; 14():20420188231160405. PubMed ID: 37006780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment.
    Milionis C; Ilias I; Venaki E; Koukkou E
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review of Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults in South Korea.
    Oh JW; Yun Y; Lee ES
    J Menopausal Med; 2022 Dec; 28(3):92-102. PubMed ID: 36647272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations on medical training for gender-affirming care: Motivations and perspectives.
    Stryker SD; Pallerla H; Pickle S
    Int J Transgend Health; 2020; 21(1):79-88. PubMed ID: 33015661
    [No Abstract]   [Full Text] [Related]  

  • 36. Fertility concerns of the transgender patient.
    Cheng PJ; Pastuszak AW; Myers JB; Goodwin IA; Hotaling JM
    Transl Androl Urol; 2019 Jun; 8(3):209-218. PubMed ID: 31380227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary care providers' willingness to continue gender-affirming hormone therapy for transgender patients.
    Shires DA; Stroumsa D; Jaffee KD; Woodford MR
    Fam Pract; 2018 Sep; 35(5):576-581. PubMed ID: 29236982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'A little bubble of utopia': constructions of a primary care-based pilot clinic providing gender affirming hormone therapy.
    Ker A; Fraser G; Fleming T; Stephenson C; da Silva Freitas A; Carroll R; Hamilton TK; Lyons AC
    Health Sociol Rev; 2021 Mar; 30(1):25-40. PubMed ID: 33622204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Amsterdam Cohort of Gender Dysphoria Study (1972-2015): Trends in Prevalence, Treatment, and Regrets.
    Wiepjes CM; Nota NM; de Blok CJM; Klaver M; de Vries ALC; Wensing-Kruger SA; de Jongh RT; Bouman MB; Steensma TD; Cohen-Kettenis P; Gooren LJG; Kreukels BPC; den Heijer M
    J Sex Med; 2018 Apr; 15(4):582-590. PubMed ID: 29463477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone health of transgender adults: what the radiologist needs to know.
    Stowell JT; Garner HW; Herrmann S; Tilson K; Stanborough RO
    Skeletal Radiol; 2020 Oct; 49(10):1525-1537. PubMed ID: 32535772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.